Search
for
Sort by
Research 361–390 of 1000+
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Cutaneous manifestations associated with substance use disorders
- Alarmin Cytokines as Central Regulators of Cutaneous Immunity
- Lysophosphatidic acid and signaling in sensory neurons
- Genetics
- Perilla frutescens: A Rich Source of Pharmacological Active Compounds
- Questionnaire Modifications and Alternative Scoring Methods of the Dermatology Life Quality Index: A Systematic Review
- The Spectrum of Cutaneous Manifestations in Lupus Erythematosus: A Comprehensive Review
- The role of WNT10B in physiology and disease: A 10-year update
- Understanding the Characteristics of the Scalp for Developing Scalp Care Products
- Lichenoid red tatoo reaction and alopecia areata
- Perceived Stigmatization among Dermatological Outpatients Compared with Controls: An Observational Multicentre Study in 17 European Countries
- Clinical Efficacy of Topical or Oral Soy Supplementation in Dermatology: A Systematic Review
- The Genus Astragalus Species as an Emerging Source of Bioactive Phytochemicals: A Review of Dermatological and Cosmetic Applications
- Advances in Nanotechnology-Based Topical Delivery Systems for Skincare Applications
- Mechanisms of proton inhibition and sensitization of the cation channel TRPV3
- Neuropeptídeos na pele
- DERMATOLOGIC DISEASES AND PROBLEMS OF WOMEN THROUGHOUT THE LIFE CYCLE
- Lichen Planus Activity and Damage Index (LiPADI)–Creation of the Questionnaire
- Essential Role of STAT3 Signaling in Hair Follicle Homeostasis
- Physiologic changes and dermatoses of pregnancy
- Peer Review Report For: Pattern changes of cutaneous dermatoses among Iraqi women preceding and during the COVID-19 pandemic [version 3; peer review: 2 approved]
- Stem Cell Therapy for Burns: Story so Far
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Mind–Body Integrative Treatment of Psychodermatoses
- Drug eruptions in dermatology
- Non‐infective mucocutaneous presentations of human immunodeficiency virus infection
- Adverse cutaneous effects of psychotropic medications
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician